|
Volumn 10, Issue 4, 2007, Pages 204-209
|
The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADIPONECTIN;
BIOLOGICAL MARKER;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
LEPTIN;
QUINAPRIL;
TETRAHYDROISOQUINOLINE DERIVATIVE;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
ENZYME IMMUNOASSAY;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
OBESITY;
PATHOPHYSIOLOGY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
VASCULAR ENDOTHELIUM;
VASODILATATION;
WEIGHT REDUCTION;
ADIPONECTIN;
ADULT;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BIOLOGICAL MARKERS;
DOUBLE-BLIND METHOD;
ENDOTHELIUM, VASCULAR;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOENZYME TECHNIQUES;
LEPTIN;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
OBESITY;
PROGNOSIS;
TETRAHYDROISOQUINOLINES;
VASODILATION;
WEIGHT LOSS;
|
EID: 38149128357
PISSN: 1520037X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1520-037X.2007.06556.x Document Type: Article |
Times cited : (13)
|
References (0)
|